For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Multiple myeloma is considered incurable, but a third of patients in a clinical trial have lived without detectable cancer for years, after facing certain death ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...